Theravance Biopharma CEO Rick Winningham's 2023 pay falls 31% to $4.3M
Theravance Biopharma reports 2023 executive compensation
By ExecPay News
Published: April 5, 2024
Theravance Biopharma reported fiscal year 2023 executive compensation information on April 5, 2024.
In 2023, three executives at Theravance Biopharma received on average a compensation package of $2.4M, a 35% decrease compared to previous year.
Average pay of disclosed executives at Theravance Biopharma
Rick E Winningham, Chief Executive Officer, received $4.3M in total, which decreased by 31% compared to 2022. 70% of Winningham's compensation, or $3M, was in stock awards. Winningham also received $251K in non-equity incentive plan, $1M in salary, as well as $5K in other compensation.
Richard Graham, Former Senior Vice President, Strategic Advisor R&D, received a compensation package of $1.4M, which increased by 32% compared to previous year. 54% of the compensation package, or $753K, was in stock awards.
Aziz Sawaf, Chief Financial Officer, earned $1.4M in 2023.
Related executives
You may also like
Source: SEC filing on April 5, 2024.